A plant-based diet combined with probiotics reduces PSA increase in men and lowers prostate cancer risk by 3x.

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery, which was approved by the FDA in 2025.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Many symptoms associated with prostate cancer, like frequent urination or difficulty peeing, may be caused by less-serious concerns. Learn more.

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

The East Hanover Health Department will host a SMAC (Sequential Multiple Analyzer Computer) Blood Testing Program from 8 a.m. to 10 a.m. on Saturday, March 14 ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.

Super Bowl ad puts male reproduction gland in the spotlight. But is that specific prostate test the best method based on experts' recommendation?

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

The Food and Drug Administration recently approved the IsoPSA blood test, which was developed by Cleveland Diagnostics, a ...

Prostate cancer is the most common cancer diagnosis in men, accounting for 30% of male cancers in 2025, and is the second ...